Voluntis was founded in 2001 by three entrepreneurs who believed that innovative medical solutions built with advanced information technologies would improve medical real-life outcomes and thus increase healthcare system efficiency. This would transform patient lives, enhance medical practices and quality of care.
Every day, Voluntis teams seek to invent secure, collaborative and patient-centric digital health solutions with a unique combination of web and mobile development excellence, medical and regulatory expertise and certified quality-oriented processes. With more than 600,000 patients managed and more than 50 programs deployed, our track record speaks for itself.
-
600,000
patients managed -
50
programs deployed
At Voluntis, we are all guided by clear and simple values:
- Patient focus: we are committed to changing the daily lives of patients by addressing their unmet needs and by empowering them to manage their chronic conditions.
- Passion for innovation: we design next-generation solutions that combine digital and medical expertise to solve the daily problems of patients and caregivers.
- Respect and integrity: everyday, we take care of the people we touch, our patients, customers, partners and employees.
- Drive for excellence: in everything we do, we behave ethically and we strive to attain the highest level of quality. Always working to enhance our processes, we are certified MDSAP USA & Canada and ISO 13485 (regarding quality management systems). We are also compliant with ISO 14971 standards (risk management). Our design methodologies embed the harmonized IEC 62304 and IEC 62366 standards (for medical device software).
Pierre LEURENT
Chief Executive Officer and Founder
Pierre has more than 15 years of international experience in software medical devices, disease management and telemedicine solutions in Europe and the United States. Before founding Voluntis in 2001, Pierre worked with General Electric Medical Systems and with HealthCenter Internet Services, an online cardiology EMR solution vendor in San Francisco. In addition, Pierre is the Director of Syntec Numérique, where he leads the telemedicine workgroup, co-leader of CSIS-CSF’s e-health workgroup and e-health advisor within Nouvelle France Industrielle’s health steering committee. Pierre is a graduate of the Ecole Centrale Paris engineering school.
Romain MARMOT
Chief Business Officer and Founder
Romain is Chief Business Officer of Voluntis. He heads the Business unit from Cambridge, MA. He has more than 15 years of experience in digital health and software medical devices. He holds an MSc from École Centrale Paris in applied mathematics.
Matthieu PLESSIS
Chief Financial Officer
Matthieu has 25 years of experience in various finance positions in the pharmaceutical, telecom and IT industries. Prior to joining Voluntis, he was CFO of eFront, a global financial software vendor. In this position, he successfully supported the group’s rapid growth as well as it’s finance and M&A operations. Previously, he worked for Glaxo and SFR-Cegetel. He is a graduate of ESSCA management school.
Geneviève D'ORSAY
Chief Medical Officer
Geneviève has more than 20 years of experience in the life sciences industry. Before joining Voluntis, she was Medical Affairs Director for Johnson & Johnson Medical Devices & Diagnostics for France & BeNeLux. Prior to this position, she worked for Altana Pharma, Chiesi and Bioprojet. She holds a doctorate in medicine and a degree in pharmacology and clinical research from University of Paris VI as well as a degree in pharmacovigilance from University Descartes, Paris.
Guillaume
FLOCH
Chief Financial Officer
Guillaume has more than 20 years of professional experience in finance, first in an audit firm, then in the biopharmaceutical sector in financial control and then in financial management. He held the position of Chief Financial Officer of Hybrigenics (biotechnology) for more than 10 years, after having been Administrative and Financial Manager at Zeneus Pharma (acquired by Cephalon). Guillaume holds a DESCF and a MSTCF from the University of Paris V.
Matthieu PLESSIS
Chief Financial Officer
Matthieu has 25 years of experience in various finance positions in the pharmaceutical, telecom and IT industries. Prior to joining Voluntis, he was CFO of eFront, a global financial software vendor. In this position he successfully conducted an IPO in Europe, as well as the trade public to private sale of the company. Previously, he worked for Glaxo, SFR-Cegetel and Cegetel Enterprises. He is a graduate of ESSCA management school.
Etienne VIAL
Chief Technology Officer and Founder
Etienne manages the innovation activities at Voluntis. Etienne has more than 12 years of experience in building frameworks, deploying m-health solutions and developing algorithms, analytic suites and interoperable software. He is a graduate of the École Centrale Paris engineering school.
Raffi KRIKORIAN
Senior Vice-President Global Quality & Regulatory Affairs
Raffi has 15+ years of experience in the medical device industry. Prior to joining Voluntis, Raffi was Manager at Hutchinson Santé, healthcare subsidiary of Hutchinson Group, where he headed R&D, manufacturing and regulatory affairs in an international environment. Raffi is a graduate of the Ecole Nationale Superieure de Chimie de Mulhouse and holds a PhD in polymer science. He also holds an MBA from ESCP Europe business school.
Damien MCKEON
Senior Vice-President Global Strategic Alliances
Damien is charged of Voluntis' pharmaceutical alliances and real-world evidence capabilities, notably in the fields of outcomes measurement and data valuation. He trained in the UK as a pharmacist and computer scientist. He has over 15 years of experience in the pharmaceutical industry and in frontline clinical healthcare (at Portsmouth Hospitals NHS Trust and multiple pharmacies). He notably worked at AXA, where he helped build an operational framework to handle outsourced medical information services for pharmaceutical partners. In 2005 he led the preparation for the first ever UK Medicines and Healthcare Products Regulatory Agency inspection of this type of provider. He joined Voluntis in Paris in 2008 to take the helm of its quality division, obtaining QMS certification for ISO:13485 in 2010 and VITM/Diabeo’s CE Mark in 2013.
Eric BAVIÈRE
Senior Vice-President Solution Design & Delivery
Eric is responsible of the Design and Delivery department, including project activities, functional design, Human Factors, UX Design and labelling. With more than 17 years of experience in medical software devices, Eric has held positions in strategy, marketing and management. He has also worked on the design and deployment of numerous projects in different therapeutic areas, both in Europe and North America. He holds a degree in Computer and Network Engineering.
Guillaume MOUCHEROUD
Vice-President Performance, Safety & Architecture
Guillaume is responsible for the architecture and performance of our solutions, algorithms, risk analysis and cybersecurity. He has 20 years of experience as a system engineer and manager. After having worked for major groups (IBM, Renault, PSA) on embedded software safety, he has dedicated most of his career to the innovative medical device industry (Diagnostica Stago, Carmat SA, Voluntis), combining his technical, regulatory and managerial expertise. Guillaume is a graduate of the Ecole Supérieure d'Electricité (Supélec) and Sciences-Po Paris.
Adeline JOSPE
Vice-President Human Resources
Vice-President of Human Resources, Adeline joined Voluntis in 2017. Graduated with a Master's degree in Labor Law, a DEA in Labor and Trade Union Law and a Master's degree in Human Resources Management, Adeline has more than 15 years of experience as a Lawyer and Human Resources Manager. Before joining Voluntis, Adeline worked for nearly 10 years for the digital services company Alten.
Aurore BEAUME
Vice-President of Global Business Development
Aurore has over 10 years of experience in innovation and healthcare, in particular in developing strategy, business models and partnerships. Before joining Voluntis, she managed the innovation consulting practices for several firms such as Altran (Arendi Consulting), Erdyn and Sogeti High Tech. She specialized in life sciences, biotechnology, healthcare and digital. She created innovation strategies and business models for start-ups as well as large groups such as Phillips, bioMérieux and Pierre Fabre. She graduated from Ecole Polytechnique and Chimie ParisTech (National Chemical Engineering Institute in Paris) and also holds a PhD in pharmaceutical organic chemistry from UPMC (formerly Pierre and Marie Curie University, part of the Sorbonne University).
-
Chief Executive Officer and Founder
Pierre
LEURENT -
Chief Business Officer and Founder
Romain
MARMOT -
Chief Technology Officer and Founder
Etienne
VIAL -
Chief Medical Officer
Geneviève
D'ORSAY, MD
-
Chief Financial Officer
Guillaume
FLOCH -
Vice-President of Global Business Development
Aurore
BEAUME -
Senior Vice-President Global Strategic Alliances
Damien
MCKEON -
Senior Vice-President
Solution
Design & DeliveryEric
BAVIÈRE
-
Vice-President Performance,
Safety & ArchitectureGuillaume
MOUCHEROUD -
Senior Vice-President Global Quality & Regulatory Affairs
Raffi
KRIKORIAN -
Vice-President Human Resources
Adeline JOSPE
Eric Elliott
Chairman of the Board of Directors
In his most recent role as Prime Therapeutics' President and Chief Executive Officer, Eric Elliott was responsible for all operating and strategic aspects of the full service pharmacy benefit management company. With approximately $17 billion in annualized drug spend under management, Prime Therapeutics is the fourth largest pharmacy benefit manager in the United States, servicing 23 health plans, other smaller pharmacy benefit managers (PBMs), and employer direct customers. Critical to the success of Prime Therapeutics, Eric led the partnership with Blue Cross and Blue Shield Plans to ensure members receive the highest quality of care while managing appropriate pharmaceutical costs and trends. Under Elliott's leadership, Prime was recognized locally and nationally by prominent publications and organizations for its employee engagement, healthy workplace, highest quality and care of service for members, and business growth. With experience running three integrated PBMs, Eric is skilled in leading and growing businesses to include line and segment expansions. He previously served as president of Cigna's Pharmacy Management and Voluntary businesses and has held senior executive level positions at Aetna, PCS HealthSystems and Rite Aid Corporation. Elliott received his bachelor's degree in management and finance, and a Master of Business Administration from Temple University in Philadelphia. He has served for many years on the board of directors at Prime, The Main Street America Group, the Pharmaceutical Care Management Association and the Twin Cities American Heart Association. Elliott also serves on The Wall Street Journal CEO Council.
Pierre LEURENT
Director and Chief Executive Officer
Pierre has more than 15 years of international experience in software medical devices, disease management and telemedicine solutions in Europe and the United States. Before founding Voluntis in 2001, Pierre worked with General Electric Medical Systems and with HealthCenter Internet Services, an online cardiology EMR solution vendor in San Francisco. In addition, Pierre is the Director of Syntec Numérique, where he leads the telemedicine workgroup, co-leader of CSIS-CSF’s e-health workgroup and e-health advisor within Nouvelle France Industrielle’s health steering committee. Pierre is a graduate of the Ecole Centrale Paris engineering school.
Jan Berger
Director
Dr. Berger is a tri-sector healthcare executive with proven results in private, public and government services over the last 30 years. In 2009, Dr. Berger founded Health Intelligence Partners as a health care consultancy where she has advised in 14 countries with both health organizations and national ministries of health. Prior to that, she served as Senior Vice President, Chief Clinical Officer and Innovation Officer for CVS Health/Caremark. She currently sits on the boards of Cambia Health Solutions, a multi-state Blue Cross Blue Shield plan; GNS Healthcare, a healthcare data analytics company; Tabula Rasa, a medication safety and management company; and Accent Care, a home health and palliative care organization. Dr. Berger is an assistant professor at Northwestern University School of Medicine and School of Communication in Chicago, Illinois. She is a renowned expert in consumer engagement and medication adherence and has authored four books and numerous publications on these topics. She holds both a Doctor of Medicine degree and a Master’s in Jurisprudence from Loyola University (Chicago, Illinois).
Laurent Higueret
Director
Laurent is an investment director in the Large Venture Fund at Bpifrance, the French Sovereign
Wealth Fund, specializing in healthcare and life sciences investments. He currently serves as board
director at Voluntis (digital therapeutics) and formerly at Biom’Up (biosurgery) and Poxel (type 2
diabetes). Laurent is also a board observer at Enyo Pharma (HBV, NASH) and GenSight Biologics (gene
therapy); and follows Bpifrance’s investments in DBV Technologies (food allergies) and MedDay
Pharmaceuticals (neurodegenerative diseases).
Before joining Bpifrance in 2014, he spent six years as an investment banker with BNP Paribas’
Healthcare M&A Group.
Laurent qualified as a Doctor of Pharmacy at the University of Bordeaux and holds a Master Degree
in Financial Engineering from the EM Lyon Business School.
Viviane Monges
Director
Viviane Monges has 30 years of experience as a Senior Executive in the finance function. She has had a successful career in international companies, holding positions in Europe, Asia and the United States, mostly in the healthcare sector. After five years at Agence France Presse in Paris and then Hong Kong, she joined the pharmaceutical industry with Wyeth, first in the French subsidiary as director of management control, then at the group's head office in Philadelphia, as Chief Financial Officer of the Europe Region, then of the Pharma Business Unit (USD 6 billion). She took an active role in many projects to transform the company, organisationally, strategically and in mergers & acquisitions and to establish the Sarbanes-Oxley rules on internal control. In 2006, Viviane joined the OTC Division at Novartis as Chief Financial Officer, Europe. She took part in many key projects, including a reorganisation of the Europe Region as well as the establishment of shared service centres. Next, she served as Global CFO of the OTC Division based in the United States (USD 3.5 billion) during the Prevacid launch. In 2010, Viviane was appointed CFO of Galderma, a Swiss pharmaceutical group specialised in dermatology (USD 2.5 billion). This group, a joint venture of Nestlé and L'Oréal, is an industry leader in Rx, OTC, and Aesthetics. In 2014, following Nestlé's acquisition of all of Galderama's shares, the latter became Nestlé Skin Health. In 2015, Viviane joined Nestlé as CFO of the Business Excellence Department, which groups together the worldwide support functions (finance, HR, IT, procurement, digital and property). For three years, Viviane has been responsible for a major programme to transform the group. In 2018, Viviane decided to focus on directorship. She is a member of the board of directors of UCB and Novo Holdings. Viviane is a graduate of ESCP, a French national, and a resident of Lausanne.
Franck Noiret
Director
Franck Noiret is Managing Director of Innovation Capital at LBO France, a leading private equity firm with over 3 billion euros under management. He joined Innovation Capital in 2005 as General Partner, and LBO France in 2016 when the firms joined forces. He is currently investing in Digital Health companies in Europe through the Services Innovants Santé et Autonomie (SISA) fund. With over 20 years of investment experience in Technology and Healthcare, Franck Noiret is currently board member of Voluntis, Entrepreneurs & Investisseurs Technologies, Kayentis, Omni Orthopaedics (US), Zesty (UK) and observer of Ekinops (EKI / Euronext). Prior to joining Innovation Capital, Franck Noiret was Director at Apax Partners in Paris where he was responsible for investments in Technology and Telecoms ranging from venture capital to growth LBO. From 1995 to 2000, Franck Noiret was Principal Banker at the European Bank for Reconstruction and Development (EBRD) where he was responsible for private and public sector investment projects in Central and Eastern Europe. De 1989 à 1993, Franck Noiret was a banker in the City of London for Société Générale after starting his career as an auditor at Arthur Andersen in Paris. Franck Noiret has a MBA from the Wharton School (US) and a Master in Corporate Finance from Paris-Dauphine University. He graduated with the highest distinction from Sciences Po Paris.
